Reactivity of serum from cattle suspected of bovine leukaemia virus infection to peptides representing mutated epitopes on envelope glycoprotein gp51

• Autorzy: Rola M , Materniak M. , Kuzmak J.
• Języki publikacji: EN

Abstrakty

EN

The ELISA technique with synthetic peptides as an antigen was developed to analyse the reactivity of bovine serum directed to mutated epitopes on envelope glycoptrotein gp51 of bovine leukaemia virus (BLV). The peptides represented normal and mutated G, H, and GG epitopes deduced from wild type BLV and its genetic variants, respectively. When 436 sera identified as seronegative by commercially available ELISA were tested by newly developed peptide ELISA, 14 samples revealed the highest reactivity. Out of them, reactivity to the mutated epitope GG was found in eight samples, while five and two samples reacted to epitopes G and H, respectively. One serum showed the reactivity to two peptides. Sera, which reacted with the epitope G, were found mostly in animals from one herd, while the distribution of sera that reacted to epitopes GG and H were less restricted to the particular herds. It has been concluded that sera showing strong reactivity to mutated peptides could represent animals infected with BLV variants, which escape antibody detection.

Słowa kluczowe

EN

genetic variant; bovine leukemia virus; cattle; veterinary medicine; ELISA test; serum; glycoprotein; peptide; animal disease; viral infection

• Wydawca: -
• Czasopismo: Bulletin of the Veterinary Institute in Puławy
• Rocznik: 2008
• Tom: 52
• Numer: 3
• Opis fizyczny: p.325-329,fig.,ref.

Twórcy

autor

Rola M

• National Veterinary Research Institute, 24-100 Pulawy, Poland

autor

Materniak M.

autor

Kuzmak J.

Bibliografia

• 1. Asfaw Y., Tsusuku S., Konishi M., Murakami K., Tsuboi T., Wu D., Sentsui H.: Distribution and superinfection of bovine leukemia virus genotypes in Japan Arch Virol 2005, 150, 493-505.
• 2. Beier D., Blankenstain P., Marquard O., Kuzmak J.: Identification of different BLV provirus isolates by PCR, RFLPA and DNA sequencing. Berl. Munch. Tierarztl Wsch 2001, 114, 252-256.
• 3. Bicka L., Rola M., Kozaczynska B., Stec J., Kuzmak J.: Characteristics of genetic mutants of bovine leukaemia virus and their role in serodiagnosing BLV infections. Medycyna Wet 2005, 61, 699-702.
• 4. Blankestein P., Fechner H., Looman A.C., Beier D., Marquardt O., Ebner D.: Polymerase chain reaction (PCR) for detection of BLV provirus-a practical complement for BLV diagnosis? Berl Munch Tierarztl Wochenschr 1998, 111, 180-186.
• 5. Bruck C., Mathot S., Portetelle D., Berte C., Franssen J.D., Herion P., Burny A.: Monoclonal antibodies define eight independent antigenic regions on the bovine leukemia virus (BLV) envelope glycoprotein gp51. Virology 1982, 122, 342-352.
• 6. Bruck C., Rensonnet N., Portetelle D., Cleuter Y., Mammerickx M., Burny A., Mamoun R., Guillemain B., Van der Maaten M.J., Ghysdael J.: Biologically active epitopes of bovine leukemia virus protein gp51: their dependence on protein glycosylation and genetic variability. Virology 1984, 136, 20-31.
• 7. Camargos M.F., Pereda A., Stancek D., Rocha M.A., dos Reis J.K.P., Greiser-Wilke I., Leite R.C.: Molecular characterization of the env gene from Brazilian field isolates of bovine leukemia virus. Virus Genes 2007, 34, 343-350.
• 8. Fechner H., Blankenstein P., Looman A.C., Elwert J., Geue L., Albrecht C., Kurg A., Beier D., Marquardt O., Ebner D.: Provirus variants of the bovine leukemia virus and their relation to the serological status of naturally infected cattle. Virology 1997, 237, 261-269.
• 9. Felmer R., Munoz G., Zuniga J., Recabal M.: Molecular analysis of a 444bp fragment of the bovine leukaemia virus gp51 env gene reveals a high frequency of non- silent point mutations and suggests the presence of two subgroups of BLV in Chile. Vet Microbiol 2005, 108, 39-47.
• 10. Grego E., Profiti M., Giammarioli M., Giannino L., Rutili D., Woodall C., Rosati S.: Genetic heterogeneity of small ruminant lentiviruses involves immunodominant epitope of capsid antigen and affects sensitivity of single-strain-based immunoassay. Clin Diagn Lab Invest 2002, 9, 828-832.
• 11. Lai R., Heneine W., Rudolph D., Present W., Hofinez D., Hartley T., Khabbaz R., Kaplan J.: Synthetic peptide- based immunoassay for distinguishing between human T- cell lymphotropic virus type I and II infections in seropositive individuals. J Clin Microbiol 1991, 29, 2253-2258.
• 12. Licursi M., Inoshima Y., Wu D., Yokoyama T., Gonzales E.T., Sentsui H.: Genetic heterogeneity among bovine leukemia genotypes and its relation to humoral responses in hosts. Virus Res 2002, 86, 101-110.
• 13. Londos-Gagliardi D., Jauvin V., Armengaut M.H., Astier-Gin T., Goetz M., Huet S., Guillemain B.J.: Influence of amino acids substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface glycoprotein: a study using monoclonal antibodies raised against relevant peptides. AIDS Res Hum Ret 1999, 15, 909-920.
• 14. Lorenz R., Straub O.: The problem of recurrence of enzootic bovine leukosis in previously cured herds. Dtsch Tierarztl Wsch 1994, 101, 158-162.
• 15. Mamoun R.Z., Morrison M., Rebeyrotte N., Busetta B., Couez D., Kettmann R., Hospital M., Guillemain B.: Sequence variability of bovine leukemia virus env gene and its relevance to the structure and antigenicity of the glycoproteins. J Virol 1990, 64, 4180-4188.
• 16. Mansky M.L.: Retrovirus mutation rates and their role in genetic variation. J Gen Virol 1998, 79, 1337-1345.
• 17. Marin M., Penton P., Bocalandro Y., Pena L., Navarro J., Lopez L.: Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus. Bioch Biophys Res Commun 2001, 289, 1-6.
• 18. Monti G., Schrijver R., Beier D.: Genetic diversity and spread of bovine leukaemia virus isolates in Argentine dairy cattle. Arch Virol 2005, 150, 443-458.
• 19. Portetelle D., Couez D., Bruck C., Kettmann R., Mammerickx M., Van der Maaten M., Brasseur R., Burny A.: Antigenic variants of bovine leukemia virus (BLV) are defined by amino acids substitutions in the NH₂ part of the envelope glycoprotein gp51. Virology 1989, 169, 27-33.
• 20. Reichert M.: Importance of a single point mutation of the bovine leukaemia virus (BLV). Bull Vet Inst Pulawy 2002, 46, 17-26.
• 21. Zhao X., Buehring G.C.: Natural genetic variations in bovine leukemia virus envelope gene: possible effects of selection and escape. Virology 2007, 366, 150-165.